1. Eriksson, J. and Fenyö, D. Improving the success rate of proteome analysis by modeling protein-abundance distributions and experimental designs. Nat. Biotechnol. 25, 651-655 (2007).
  2. Stasyk, T. and Huber, L. A. Zooming in: fractionation strategies in proteomics, Proteomics 4, 3704-3716 (2004).
  3. Lescuyer, P. et al. Comprehensive proteome analysis by chromatographic protein prefractionation, Electrophoresis 25, 1125-1135 (2004).
  4. Hoffman, S. A. et al. Higher dimensional (Hi-D) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma. J. Chromatogr. B 849, 43-52 (2006).
  5. Hyoung-Joo, L. et al. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics. Curr. Opin. Chem. Biol. 10, 42-49 (2006).
  6. Bodzon-Kulakowska, A. et al. Methods for samples preparation in proteomic research. J. Chromatogr. B 849, 1-31 (2007).
  7. Tang, J. et al. Recent development of multi-dimensional chromatography strategies in proteome research. J. Chromatogr. B 866, 123-132 (2008).
  8. Anderson, N. L. and Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867 (2002).
  9. Hortin, G. L. et al. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 54, 1608-1616 (2008).
  10. Pernemalm, M. et al. Affi nity prefractionation for MS-based plasma proteomics. Proteomics 9, 1420-1427 (2009).
  11. Xiangming, F. et al. Affi nity separation and enrichment methods in proteomic analysis, J. Proteomics 71, 284-303 (2008).
  12. Pieper, R. et al. Multi-component immunoaffi nity subtraction chromatography: an innovative step toward a comprehensive survey of the human plasma proteome, Proteomics 3, 422-432 (2002).
  13. Bjorhall, K. et al. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5, 307-317 (2005).
  14. Gong, Y. et al. Different immunoaffi nity fractionation strategies to characterize the human plasma proteome. J. Proteome Res. 5, 1379-1387 (2006).
  15. Pernemalm, M. et al. Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery. J. Proteome Res. 7, 2712-2722 (2008).
  16. Gao, M. et al. Large scale depletion of the high-abundance proteins and analysis of middle- and low-abundance proteins in human liver proteome by multidimensional liquid chromatography. Proteomics 8, 939-947 (2008).
  17. Azarkan, M. et al. Affi nity chromatography: a useful tool in proteomics studies. J. Chromatogr. B 849, 81-90 (2007).



お問合せ内容[必須] お名前[必須]  

注)機種依存文字(①、② など)は使用できません。
電話[必須] - - (内線
ご記入いただく個人情報は、当社製品・サービスの提供及び販売促進、当社製品に関する情報の収集・分析及び提供、新製品・新サービスの研究開発等並びに市場調査のために利用します。当社は個人情報を業務委託先に預ける場合がありますが、個人情報の取扱いに関する法令、国が定める指針その他の規範に従い、委託先に対する必要かつ適切な監督を行います。個人情報に関するお問い合わせは総合お問合せ窓口(03-5331-9336:営業日 9:00〜12:00、13:00〜17:30)にて承ります。
グローバルライフサイエンステクノロジーズジャパン株式会社 個人情報管理責任者